Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment (Q36609698)
Jump to navigation
Jump to search
scientific article published on January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment |
scientific article published on January 2007 |
Statements
1 reference
Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment (English)
1 reference
D Cunningham
1 reference
N Starling
1 reference
D Tilden
1 reference
J White
1 reference
1 January 2007
1 reference
1 reference
206-212
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference